| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6bc2fc3df62b26074772600f612a02f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37 |
| filingDate |
1983-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fbc36cf3237468eb5fc18c209f3418c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1750f53d8ab91f1a19506d5966126383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5999a809e31f3f3891a56ba2df69afea |
| publicationDate |
1984-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2129685-A |
| titleOfInvention |
Anti-haemophilic compositions |
| abstract |
An intravenous anti-haemophilic pharmaceutical composition contains a mixture of phospholipid and Factor VIII in a ratio of at least 2.5 mu g of phospholipid per international unit of Factor VIII. The phospholipid in the mixture must contain at least 15% of phosphatidyl serine (PS). The composition may be prepared by dispersing PS-rich phoshpolipid in an aqueous solution to afford an emulsion and then incubating the phospholipid emulsion with Factor VIII. Freeze-drying the phospholipid/Factor VIII mixture obtained gives a composition in a form convenient for medical use. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7892522-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6017891-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0253870-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0680763-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0680764-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0680764-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9352027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0680763-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9805364-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9805364-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018039754-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8765665-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372800-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020459-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0253870-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9669076-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512674-B2 |
| priorityDate |
1982-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |